CHRNA4 and neoplasm: It also strengthen the therapeutic value of a drug-induced cancer stem cell differentiation and suggest that selective nicotinic-Acetyl Choline Receptor (nAChR) targeting as a potential novel therapeutic strategy for these universally lethal neoplasms.